Previous Events

Q2 2026 Half-Year Report Presentation
favorite_border
Virtual
Thu, 20 Aug 10:00 AM
CEO Bent Frandsen and CFO Keith Alexander will present ExpreS2ion’s Q2 2026 half-year report at a virtual investor event hosted…
 
Morgenbørs Live Podcast Interview with CEO Bent Frandsen
favorite_border
Virtual
Fri, 14 Aug 08:50 AM
CEO Bent Frandsen will join Morgenbørs, H.C. Andersen Capital’s daily live podcast covering Danish and US equities, for a short…
 
Q1 2026 interim report presentation
favorite_border
Virtual
Thu, 28 May 10:00 AM
CEO Bent Frandsen and CFO Keith Alexander will present ExpreS2ion’s Q1 2026 interim report at a virtual investor event hosted…
 
Global Forum (BioStock)
favorite_border
Lund, Sweden
Thu, 21 May , All Day
ExpreS2ion will participate in Global Forum 2026, hosted by BioStock in Lund. Global Forum brings together Nordic and international life…
 
Life Science Investor Conference (Økonomisk Ugebrev)
favorite_border
Copenhagen, Denmark
Wed, 25 Mar , All Day
ExpreS2ion will participate in the Life Science Investor Conference hosted by Økonomisk Ugebrev in Copenhagen. Økonomisk Ugebrev is a Danish…
 
19th European Life Sciences Forum (ELSF)
favorite_border
Zurich, Switzerland
ExpreS2ion will participate in the 19th European Life Sciences Forum (ELSF), an international partnering and investor conference focused on biotechnology,…
 
Presentation of 2025 fourth quarter and full-year results
favorite_border
Virtual
Thu, 19 Feb 09:30 AM
CEO Bent Frandsen and CFO Keith Alexander will present the 2025 Full-year results at a virtual live event for investors…
 
Redeye Theme: Fight Cancer
favorite_border
Stockholm, Sweden
Wed, 21 Jan 10:50 AM
ExpreS2ion will participate in Redeye Theme: Fight Cancer 2026, a focused life sciences investor event highlighting Nordic companies active in…
 
BioStock Life Science Summit
favorite_border
Lund, Sweden
Thu, 13 Nov 02:55 PM
Join ExpreS2ion at BioStock’s Life Science Summit 2025 Meet our CEO, Bent Frandsen, at BioStock’s “Life Science Summit” Summit, taking…
 
2025 Interim Report (Q3) Presentation
favorite_border
Virtual
Thu, 13 Nov 11:00 AM
ExpreS2ion Biotechnologies – 2025 Interim Report (Q3) Presentation CEO Bent Frandsen and CFO Keith Alexander will present ExpreS2ion Biotechnologies’ 2025…